BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/05/2026

FDA Classifies Circulating Tumor Cell Enrichment Device as Class II

The FDA has classified the circulating tumor cell enrichment device as Class II, a move expected to enhance patients' access to innovative devices while ensuring safety and effectiveness.

Source: Federal Register — Food and Drug AdministrationOpen original release →